EGB Ventures

EGB Ventures creates innovative new companies focused on advancing clinical-stage pharmaceutical products that address critical, unmet medical needs. We build, invest in, and support these ventures by collaborating closely with talented executives and strategic investment partners to drive impactful progress and long-term value. We aim to conduct initial public offerings for these companies at the earliest feasible timeframe, subject to global market conditions.

We typically form new ventures, often recruiting executives, and actively partner with other investors to further our portfolio companies.